Suppr超能文献

布加综合征猝死风险:临床与解剖学方面

When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects.

作者信息

Stazi Filippo, Battisti Paola

机构信息

UOS Week Cardiology, UOC Emergency Cardiology, San Giovanni-Addolorata Hospital, Rome, Italy.

UOSD Internal Medicine with Dysmetabolic Diseases, San Giovanni-Addolorata Hospital, Rome, Italy.

出版信息

Eur Heart J Suppl. 2022 Nov 12;24(Suppl I):I165-I169. doi: 10.1093/eurheartjsupp/suac088. eCollection 2022 Nov.

Abstract

The current prognostic stratification of asymptomatic patients with Brugada syndrome is suboptimal. The so-called 'Brugada burden' concept is certainly emerging: the more extensive are the electrocardiographic alterations of the syndrome in space (peripheral as well as precordial derivations) and in time (persistence in the follow-up of electrocardiographic alterations), the greater the probability of arrhythmic events. Numerous clinical and electrocardiographic markers have been considered risk factors, but none of them alone is able to guide the choice of whether or not to implant a defibrillator, the only therapy so far proved effective in preventing SD (sudden death) in these patients. The prognostic value of the electrophysiology study also gradually decreased over time. Therapeutic decisions must therefore be taken, at the moment, considering a large number of variables, possibly included in risk scores to be validated prospectively and in large series. Magnetic resonance and the study of electro-anatomical alterations of the right ventricular outflow tract will most likely improve our prognostic stratification capacity in the future.

摘要

目前,无症状 Brugada 综合征患者的预后分层并不理想。所谓的“Brugada 负荷”概念正在逐渐形成:该综合征的心电图改变在空间上(外周及胸前导联)和时间上(心电图改变在随访中的持续情况)越广泛,发生心律失常事件的可能性就越大。许多临床和心电图指标都被视为危险因素,但单独任何一项都无法指导是否植入除颤器的决策,而除颤器是目前唯一被证明对预防这些患者心源性猝死有效的治疗方法。随着时间的推移,电生理检查的预后价值也逐渐降低。因此,目前必须综合考虑大量变量来做出治疗决策,这些变量可能纳入风险评分中,并有待在前瞻性大样本研究中进行验证。磁共振成像以及右心室流出道电 - 解剖改变的研究很可能在未来提高我们的预后分层能力。

相似文献

1
When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects.
Eur Heart J Suppl. 2022 Nov 12;24(Suppl I):I165-I169. doi: 10.1093/eurheartjsupp/suac088. eCollection 2022 Nov.
3
Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
J Am Coll Cardiol. 2015 Mar 10;65(9):879-88. doi: 10.1016/j.jacc.2014.12.031.
5
Prognosis, risk stratification, and management of asymptomatic individuals with Brugada syndrome: A systematic review.
Pacing Clin Electrophysiol. 2017 Dec;40(12):1332-1345. doi: 10.1111/pace.13214. Epub 2017 Nov 15.
7
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study.
JACC Clin Electrophysiol. 2021 Oct;7(10):1264-1273. doi: 10.1016/j.jacep.2021.03.010. Epub 2021 Apr 28.

本文引用的文献

3
Does the Age of Sudden Cardiac Death in Family Members Matter in Brugada Syndrome?
J Am Heart Assoc. 2021 Jun;10(11):e019788. doi: 10.1161/JAHA.120.019788. Epub 2021 May 20.
4
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK).
JACC Clin Electrophysiol. 2021 Feb;7(2):210-222. doi: 10.1016/j.jacep.2020.08.032. Epub 2020 Oct 28.
6
Long-term prognosis of women with Brugada syndrome and electrophysiological study.
Heart Rhythm. 2021 May;18(5):664-671. doi: 10.1016/j.hrthm.2020.12.020. Epub 2020 Dec 24.
7
Significance of Exercise-Related Ventricular Arrhythmias in Patients With Brugada Syndrome.
J Am Heart Assoc. 2020 Dec;9(23):e016907. doi: 10.1161/JAHA.120.016907. Epub 2020 Nov 23.
8
The utility of drug challenge testing in Brugada syndrome: A systematic review and meta-analysis.
J Cardiovasc Electrophysiol. 2020 Sep;31(9):2474-2483. doi: 10.1111/jce.14631. Epub 2020 Jul 9.
9
Wide QRS complex and the risk of major arrhythmic events in Brugada syndrome patients: A systematic review and meta-analysis.
J Arrhythm. 2019 Dec 27;36(1):143-152. doi: 10.1002/joa3.12290. eCollection 2020 Feb.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验